To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection

NCT04706468 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Virus Infection

Interventions

DRUG: TG-1000

Sponsor

TaiGen Biotechnology Co., Ltd.

Collaborators

[object Object]